Почетна › Имуни систем и поремећаји › Kalifornija
Kliničke studije za Имуни систем и поремећаји u državi Kalifornija
19 studija za Имуни систем и поремећаји traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- Los Angeles9 студија
- Baldwin Park5 студија
- San Diego4 студија
- Mountain View3 студија
- San Francisco3 студија
Zvanični tekst studije (na engleskom)
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Kern Research, Inc., Bakersfield
- First OC Dermatology Research Inc, Fountain Valley
- Northridge Clinical Trials, Northridge
- и још 2
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07765888A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Kern Research, Inc., Bakersfield
- First OC Dermatology Research Inc, Fountain Valley
- Marvel Clinical Research, Huntington Beach
- и још 4
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07783425Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- PCR Oncology, Arroyo Grande
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
- Washington Health, Fremont
- и још 3
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 4. 11. 2026. · NCT04242095A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06722235A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Chula Vista
Тражи се учесникФаза 2
Узраст од 18 до 60 · Оба пола · Ажурирано 30. 10. 2026. · NCT07541287A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06948318A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Stanford University, Dept. of Dermatology, Redwood City
- UC Davis, Dept. of Dermatology, Sacramento
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- City of Hope, Duarte
- Providence St. John's Health Center, Santa Monica
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03328078A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07192471(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04996875A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- City of Hope, Duarte
- Stanford University, Palo Alto
- UCSF, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 8. 2026. · NCT07075185Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of California-Irvine Medical Center, Irvine
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
- и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT05826535A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
Тражи се учесникФаза 2
Узраст од 18 до 74 · Оба пола · Ажурирано 12. 8. 2026. · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443Atacicept in Multiple Glomerular Diseases
- Vera Therapeutics, Brisbane
Тражи се учесникФаза 2
Узраст 2 и старији · Оба пола · Ажурирано 26. 6. 2026. · NCT06983028A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 2. 6. 2026. · NCT05787574Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
- USC / Norris Comprehensive Cancer Center, Los Angeles
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 19 и старији · Оба пола · Ажурирано 2. 4. 2026. · NCT03207854A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- City of Hope National Medical Center, Duarte
- Ronald Regan UCLA Medical Center, Los Angeles
- University of California Irvine Health, Orange
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 15. 12. 2025. · NCT06619561Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 29. 4. 2022. · NCT04684602Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.